Earnings Preview For TG Therapeutics
Portfolio Pulse from Benzinga Insights
TG Therapeutics (NASDAQ:TGTX) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $-0.10. The company's past performance shows a history of beating EPS estimates, which has positively impacted its share price in the short term. However, over the last 52 weeks, TGTX shares have declined by 8.88%, indicating potential concerns among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.
February 27, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TG Therapeutics is expected to report an EPS of $-0.10 for the upcoming quarter. Historical data shows positive share price movements following earnings beats. However, the stock has experienced an 8.88% decline over the past year, indicating potential volatility around the earnings announcement.
TG Therapeutics has a history of beating EPS estimates, which typically results in positive short-term share price movements. However, the overall negative performance over the past year suggests that investor sentiment is mixed, and the upcoming earnings report could swing the stock in either direction, depending on whether the company meets or exceeds expectations and what guidance it provides for future quarters.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100